Shield Therapeutics (STX)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

 6.35p
   
  • Change Today:
      0.000p
  • 52 Week High: 12.20
  • 52 Week Low: 2.40
  • Currency: UK Pounds
  • Shares Issued: 1,068.42m
  • Volume: 1,573,156
  • Market Cap: £67.84m
  • Beta: 0.03

Latest Deals

No deals were found in the last 365 days.

Largest Deals (365 days)

No deals were found in the last 365 days.

Director Shareholdings

Notifier Holding Value*
Hans-Peter Hasler 5,500,000 £349,250
Anders Lundstrom 575,000 £36,512

Major Shareholders

Notifier** Holding Value*
AOP Orphan Pharmaceuticals AG 158,070,394 £10,037,470
Nutrition-Wellness Venture SA 56,008,541 £3,556,542
Jupiter Fund Management plc 34,127,697 £2,167,109
MaRu AG 12,532,918 £795,840
JPMorgan Asset Management Holdings Inc. 6,238,846 £396,167
Universities Superannuation Scheme Ltd 5,067,985 £321,817
Spreadex Ltd 4,123,006 £261,811

* Value is calculated by using the current share price multiplied by the amount held.
** Major Shareholders are individuals or institutions that own more than 3% of the company’s shares and have been reported in the annual accounts.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

STX Market Data

Currency UK Pounds
Share Price 6.35p
Change Today 0.000p
% Change 0.00 %
52 Week High 12.20
52 Week Low 2.40
Volume 1,573,156
Shares Issued 1,068.42m
Market Cap £67.84m
Beta 0.03

STX Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
12.49% below the market average12.49% below the market average12.49% below the market average12.49% below the market average12.49% below the market average
70.73% above the sector average70.73% above the sector average70.73% above the sector average70.73% above the sector average70.73% above the sector average
Price Trend
58.74% above the market average58.74% above the market average58.74% above the market average58.74% above the market average58.74% above the market average
77.27% above the sector average77.27% above the sector average77.27% above the sector average77.27% above the sector average77.27% above the sector average
Income Not Available
Growth
64.03% above the market average64.03% above the market average64.03% above the market average64.03% above the market average64.03% above the market average
79.31% above the sector average79.31% above the sector average79.31% above the sector average79.31% above the sector average79.31% above the sector average

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

STX Dividends

No dividends found

Trades for 22-May-2026

Time Volume / Share Price
16:09 20 @ 6.50p
15:19 320 @ 6.50p
15:00 35,382 @ 6.33p
14:21 15,946 @ 6.34p
12:21 10,000 @ 6.34p

STX Key Personnel

CEO Anders Lundstrom

Top of Page